India to Germany: Irinotecan Export Trade Route

The India to Germany Irinotecan corridor is one of India's established pharmaceutical export routes, with 470 shipments documented worth a combined $8.1M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's irinotecan manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $17.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with irinotecan's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 24.2%, placing it at rank #17 among India's top irinotecan export destinations globally.

On the import side, key buyers of Indian irinotecan in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH , VENUS PHARMA GMBH and 4 others. FRESENIUS KABI DEUTSCHLAND GMBH is the single largest importer with 280 shipments valued at $4.9M USD.

India's irinotecan exports to Germany are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 280 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , VENUS REMEDIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $17.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as irinotecan kabi inj.500mg/25ml vial b.no and irinotecan kabi inj.300mg/15ml vial b.no , suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer with 280 shipments worth $4.9M USD — representing 60% of all irinotecan imports from India on this route. A total of 7 buyers are active on this corridor.